Review article · 2018
EditorialPublished 2013
Recent Developments in EU and US Pharmacovigilance Legislation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The evolution of EU and US pharmacovigilance legislation highlights two trends. The first is to strengthen the instruments of protection of human health through, inter alia, the continuous monitoring of the risk-benefit ratio of drugs, greater transparency and the power to penalize producers for the failure to meet the pharmacovigilance obligations. The second trend manifests the partial harmonization of the different pharmacovigilance systems. However, this goal is still far away. In order to achieve it would be necessary to establish an identical definition of adverse drug reaction in both the EU and US legislation.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Aug 2023
Novelties of pharmacovigilance legislation in Eurasian Economic Union
Conference abstract
New European pharmacovigilance legislation; Current status and issues - The generics perspective
Conference abstract
Challenges from the new European pharmacovigilance legislation and their implementation by competent authorities
Conference abstract
Role of regulatory affairs in pharmacovigilance: Marketing authorizations and new pharmacovigilance legislation in EU: Important changes, challenges and options
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Advancing Patient Safety Through Modern Pharmacovigilance Practices
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gianluca Montanari-Vergallo”

